Picture of Immunotech Laboratories logo

IMMB Immunotech Laboratories Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Immunotech Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2001
December 31st
C2002
December 31st
C2003
December 31st
2004
December 31st
2005
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB/A10KSB/A10KSB/A10KSB
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.754-1.54-0.615-0.111-33.6
Depreciation
Non-Cash Items0.1530.6260.015033.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4720.4730.5410.0860.145
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.11-0.414-0.057-0.025-0.284
Capital Expenditures-0.009-0.027000
Purchase of Fixed Assets
Other Investing Cash Flow Items0-0.083000
Change in Net Investments
Change in Net Intangibles
Cash from Investing Activities-0.009-0.11000
Financing Cash Flow Items0.123
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.1860.4690.0510.020.33
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.066-0.058-0.004-0.0050.047